“A malaria drug widely touted by President Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals,” the AP reports.
“There were more deaths among those given hydroxychloroquine versus standard care, researchers reported.”
Save to Favorites